Biotech Firm FibroGen Cuts 32% Of Staff After Recent Clinical Trial Failures
FibroGen joins Illumina and Genentech in implementing job cuts among Bay Area biotech firms this year.
FibroGen joins Illumina and Genentech in implementing job cuts among Bay Area biotech firms this year.